Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany · Delayed Price · Currency is EUR 388.10
+0.85 (0.22%)
At close: Dec 22, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €99.33 billion as of December 22, 2025. Its market cap has decreased by -12.46% in one year.
Market Cap
99.33B
Enterprise Value
90.68B
Revenue
9.99B
Ranking
n/a
PE Ratio
31.71
Stock Price
€388.10
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 99.33B, an increase of 134,340.70%. That is a compound annual growth rate of 23.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 98.78B | -1.39% |
| Dec 31, 2024 | 100.17B | 5.60% |
| Dec 29, 2023 | 94.86B | 36.76% |
| Dec 30, 2022 | 69.36B | 41.28% |
| Dec 31, 2021 | 49.09B | -2.28% |
| Dec 31, 2020 | 50.24B | 0.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 51.87B |
| Siemens Healthineers AG | 49.61B |
| Bayer Aktiengesellschaft | 35.25B |
| Fresenius SE & Co. KGaA | 27.20B |
| Sartorius Aktiengesellschaft | 14.73B |
| Fresenius Medical Care AG | 11.50B |
| Fielmann Group AG | 3.62B |
| Carl Zeiss Meditec AG | 3.51B |